Works by Wu, Yi‐Long


Results: 130
    1
    2
    3

    Plasma extracellular vesicle microRNAs for pulmonary ground-glass nodules.

    Published in:
    Journal of Extracellular Vesicles, 2019, v. 8, n. 1, p. 1, doi. 10.1080/20013078.2019.1663666
    By:
    • Zhang, Jia-Tao;
    • Qin, Hao;
    • Man Cheung, Fiona Ka;
    • Su, Jian;
    • Zhang, Da-Dong;
    • Liu, Shi-Yi;
    • Li, Xiao-Fang;
    • Qin, Jing;
    • Lin, Jun-Tao;
    • Jiang, Ben-Yuan;
    • Song Dong;
    • Liao, Ri-Qiang;
    • Qiang, Nie;
    • Yang, Xue-Ning;
    • Tu, Hai-Yan;
    • Zhou, Qing;
    • Yang, Jin-Ji;
    • Zhang, Xu-Chao;
    • Zhang, Ya-Nan;
    • Wu, Yi-Long
    Publication type:
    Article
    4
    5
    6

    Lung Cancer Working Group Report.

    Published in:
    Japanese Journal of Clinical Oncology, 2010, v. 40, n. suppl_1, p. i7, doi. 10.1093/jjco/hyq121
    By:
    • Saijo, Nagahiro;
    • Fukuoka, Masahiro;
    • Thongprasert, Sumitra;
    • Ichinose, Yukito;
    • Mitsudomi, Tetsuya;
    • Mok, Tony Shu Kam;
    • Ohe, Yuichiro;
    • Park, Keunchil;
    • Wu, Yi-Long
    Publication type:
    Article
    7
    8

    Does EGFR Mutation Type Influence Patient-Reported Outcomes in Patients with Advanced EGFR Mutation-Positive Non-Small-Cell Lung Cancer? Analysis of Two Large, Phase III Studies Comparing Afatinib with Chemotherapy (LUX-Lung 3 and LUX-Lung 6).

    Published in:
    Patient, 2018, v. 11, n. 1, p. 131, doi. 10.1007/s40271-017-0287-z
    By:
    • Wu, Yi-Long;
    • Hirsh, Vera;
    • Sequist, Lecia;
    • Hu, Cheng-Ping;
    • Feng, Jifeng;
    • Lu, Shun;
    • Huang, Yunchao;
    • Schuler, Martin;
    • Mok, Tony;
    • Yamamoto, Nobuyuki;
    • O'Byrne, Kenneth;
    • Geater, Sarayut;
    • Zhou, Caicun;
    • Massey, Dan;
    • Märten, Angela;
    • Lungershausen, Juliane;
    • Yang, James
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25

    Updated Overall Survival in a Randomized Study Comparing Dacomitinib with Gefitinib as First-Line Treatment in Patients with Advanced Non-Small-Cell Lung Cancer and EGFR-Activating Mutations.

    Published in:
    Drugs, 2021, v. 81, n. 2, p. 257, doi. 10.1007/s40265-020-01441-6
    By:
    • Mok, Tony S.;
    • Cheng, Ying;
    • Zhou, Xiangdong;
    • Lee, Ki Hyeong;
    • Nakagawa, Kazuhiko;
    • Niho, Seiji;
    • Chawla, Alka;
    • Rosell, Rafael;
    • Corral, Jesus;
    • Migliorino, Maria Rita;
    • Pluzanski, Adam;
    • Noonan, Kay;
    • Tang, Yiyun;
    • Pastel, Malaika;
    • Wilner, Keith D.;
    • Wu, Yi-Long
    Publication type:
    Article
    26
    27
    28
    29
    30

    Intratumoral genetic and immune microenvironmental heterogeneity in T4N0M0 (diameter ≥ 7 cm) non‐small cell lung cancers.

    Published in:
    Thoracic Cancer, 2022, v. 13, n. 9, p. 1333, doi. 10.1111/1759-7714.14393
    By:
    • Zhang, Jia−Tao;
    • Dong, Song;
    • Ji, Li−Yan;
    • Zhou, Jia−Ying;
    • Chen, Zhi− Hong;
    • Su, Jian;
    • Zhu, Qing−Ge;
    • Wang, Meng−Min;
    • Ke, E−E.;
    • Sun, Hao;
    • Li, Xue−Tao;
    • Yang, Jin−Ji;
    • Zhou, Qing;
    • Zhang, Xu− Chao;
    • Gao, Xuan;
    • Yang, Xue−Ning;
    • Xia, Xuefeng;
    • Yi, Xin;
    • Zhong, Wen−Zhao;
    • Wu, Yi−Long
    Publication type:
    Article
    31

    High SHP2 expression determines the efficacy of PD‐1/PD‐L1 inhibitors in advanced KRAS mutant non‐small cell lung cancer.

    Published in:
    Thoracic Cancer, 2021, v. 12, n. 19, p. 2564, doi. 10.1111/1759-7714.14137
    By:
    • Feng, Hui‐Bo;
    • Chen, Yu;
    • Xie, Zhi;
    • Jiang, Jie;
    • Zhong, Yu‐Min;
    • Guo, Wei‐Bang;
    • Yan, Wen‐Qing;
    • Lv, Zhi‐Yi;
    • Lu, Dan‐Xia;
    • Liang, Hong‐Ling;
    • Xu, Fang‐Ping;
    • Yang, Jin‐Ji;
    • Yang, Xue‐Ning;
    • Zhou, Qing;
    • Zhang, Dong‐Kun;
    • Zhang, Zhou;
    • Chuai, Shao‐Kun;
    • Zhang, Heng‐Hui;
    • Wu, Yi‐Long;
    • Zhang, Xu‐Chao
    Publication type:
    Article
    32
    33
    34

    Quantitative multiplex immunofluorescence analysis identifies infiltrating PD1<sup>+</sup>CD8<sup>+</sup> and CD8<sup>+</sup> T cells as predictive of response to neoadjuvant chemotherapy in breast cancer.

    Published in:
    Thoracic Cancer, 2020, v. 11, n. 10, p. 2941, doi. 10.1111/1759-7714.13639
    By:
    • Liang, Hongling;
    • Li, Hongsheng;
    • Xie, Zhi;
    • Jin, Tianen;
    • Chen, Yu;
    • Lv, Zhiyi;
    • Tan, Xiaojun;
    • Li, Jia;
    • Han, Guodong;
    • He, Weixing;
    • Qiu, Ni;
    • Jiang, Ming;
    • Zhou, Jie;
    • Xia, Haoming;
    • Zhan, Yongtao;
    • Cui, Lulu;
    • Guo, Weiling;
    • Huang, Jianqing;
    • Zhang, Xuchao;
    • Wu, Yi‐long
    Publication type:
    Article
    35
    36

    Genomic characteristics and drug screening among organoids derived from non‐small cell lung cancer patients.

    Published in:
    Thoracic Cancer, 2020, v. 11, n. 8, p. 2279, doi. 10.1111/1759-7714.13542
    By:
    • Chen, Jing‐Hua;
    • Chu, Xiang‐Peng;
    • Zhang, Jia‐Tao;
    • Nie, Qiang;
    • Tang, Wen‐Fang;
    • Su, Jian;
    • Yan, Hong‐Hong;
    • Zheng, Hong‐Ping;
    • Chen, Ze‐Xin;
    • Chen, Xin;
    • Song, Meng‐Meng;
    • Yi, Xin;
    • Li, Pan‐Song;
    • Guan, Yan‐Fang;
    • Li, Gang;
    • Deng, Chu‐Xia;
    • Rosell, Rafael;
    • Wu, Yi‐Long;
    • Zhong, Wen‐Zhao
    Publication type:
    Article
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49

    An open label, safety study of Asian patients with advanced non-small-cell lung cancer receiving second-line nivolumab monotherapy (CheckMate 870).

    Published in:
    Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221138380
    By:
    • Lu, Shun;
    • Cheng, Ying;
    • Zhou, Jianying;
    • Wang, Mengzhao;
    • Zhao, Jun;
    • Wang, Baocheng;
    • Chen, Gongyan;
    • Feng, Jifeng;
    • Ma, Zhiyong;
    • Wu, Lin;
    • Wang, Changli;
    • Ma, Kewei;
    • Zhang, Shucai;
    • Liang, Jun;
    • Song, Yong;
    • Wang, Jie;
    • Wu, Yi-Long;
    • Li, Ang;
    • Huang, Yizhi;
    • Chang, Jianhua
    Publication type:
    Article
    50